Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: Involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway

Journal of Clinical Endocrinology and Metabolism

Volumn 80, Issue 10, 1995, Pages 2888-2893

  Clifton, Vicki L ^a   Read, Mark A ^a   Leitch, Ian M ^a   Giles, Warwick B ^a   Boura, Alan L A ^a   Robinson, Phillip J ^a   Smith, Roger ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; CYCLIC GMP; INDOMETACIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; DIASTOLIC BLOOD PRESSURE; DOPPLER FLOWMETRY; ENZYME INHIBITION; FEMALE; FETOPLACENTAL UNIT; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MATERNAL HYPERTENSION; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL ARTERY; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ADULT; BIRTH WEIGHT; COMPARATIVE STUDY; CORTICOTROPIN-RELEASING HORMONE; CYCLIC GMP; DIABETES, GESTATIONAL; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FETAL GROWTH RETARDATION; FETUS; HUMAN; IN VITRO; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; PLACENTA; POTASSIUM CHLORIDE; PREGNANCY; PREGNANCY COMPLICATIONS; REFERENCE VALUES; REGRESSION ANALYSIS; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION;

EID: 0028849723     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.80.10.7559870     Document Type: Article

References (42)

1. MacCannell KL, Hamilton PL, Lederis K, Newton CA, Rivier J. 1984 Corticotropin-releasing factor-like peptides produce selective dilatation of the dog mesenteric circulation. Gastroenterology. 87: 94-102.
2. Hermus ARMM, Pieter GFFM, Willemsen JJ, Ross HA, Smals AGH, Benraad TJ, Kloppenborg PWC. 1987 Hypotensive effects of ovine and human corticotropin-releasing factors in man. Eur J Clin Pharmacol. 31:531-534.
3. Kiang JG, Wei ET. 1992 Corticotropin-releasing factor inhibits thermal injury. Pharmacol Exp Ther. 243:517-520.
4. Corder R, Turnill D, Ling N, Gaillard RC. 1992 Attenuation of corticotropin-releasing factor induced hypotension in anaethetised rats with CRF antagonist; comparison with effect on ACTH release. Peptides. 13:1-6.
5. Lei S, Richter R, Bienert M, Mulvany MJ. 1993 Relaxing actions of corticotropin-releasing factor on rat resistance arteries. Br J Pharmacol. 108:941-947.
6. Orth DN. 1992 Corticotropin-releasing hormone in humans. Endocr Rev. 13:164-191.
7. Chan EC, Smith R, Lewin T, et al. 1993 Plasma corticotropin releasing hormone, beta-endorphin and cortisol inter-relationships during pregnancy. Acta Endocrinol (Copenh). 128:1-6.
8. Clifton VL, Read MA, Leitch IM, Boura ALA, Robinson PJ, Smith R. 1994 Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation. J Clin Endocrinol Metab. 76: 666-669.
9. Campbell EA, Linton EA, Wolfe CDA, Scraggs PR, Jones MT, Lowry PJ. 1987 Plasma corticotropin releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab. 64:1054-1059.
10. Sasaki S, Shinkawa O, Margioris AN, et al. 1987 Immunoreactive corticotropin-releasing hormone human plasma during pregnancy, labor and delivery. J Clin Endocrinol Metab. 64:224-229.
11. Stalla GK, Bost H, Stalla J, et al. 1989 Human corticotropin-releasing hormone during pregnancy. Gynecol Endocrinol. 3:1-10.
12. Dashwood MR, Andrews HE, Wei ET. 1987 Binding of Tyr-corti-cotropin-releasing factor to rabbit aorta is reduced by the removal of the endothelium. Eur J Pharmocol. 135:111-112.
13. Wolfe CDA, Patel SP, Linton EA, et al. 1988 Plasma corticotropin-releasing factor in abnormal pregnancy. Br J Obstet Gynaecol. 95: 1003-1006.
14. Goland RS, Jozak S, Warren WB, Conwell IM, Stark RI, Tropper PJ. 1993 Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J Clin Endocrinol Metab. 77:1174-1179.
15. Trudinger BJ, Giles WB, Cook CM, Bombardieri J, Collins L. 1985 Umbilical artery flow velocity waveforms and placental resistance: clinical significance. Br J Obstet Gynaecol. 92:23-30.
16. Thompson RA, Trudinger BJ, Cook CM, Giles WB. 1988 Umbilical artery velocity waveforms: normal reference values for AB ratio and Pourcelot ratio. Br J Obstet Gynaecol. 95:589-595.
17. Mak KK-W, Gude NM, Walters WAW, Boura ALA. 1984 Effects of vasoactive autacoids on the human umbilical-fetal placental vasculature. Br J Obstet Gynaecol. 91:99-106.
18. Penfold P, Drury L, Simmonds R, Hytten FE. 1981 Studies in a single placental cotyledon in vitro, I. The preparation and its viability. Placenta. 2:149-154.
19. Bowman WC, Rand MJ. 1980 Textbook of pharmacology, 2nd ed. Oxford: Blackwell; 41-48.
20. 2 receptor-mediated vasoconstriction in the fetal vessels of the human perfused placenta. Placenta. 13:597-605.
21. Boura ALA, Walters WAW, Read MA, Leitch IM. 1994 Autacoids and control of human placental blood flow. Clin Exp Pharmacol Physiol. 21:737-748.
22. Coleman RA, Smith WC, Narumiya S. 1994 VIII International Union of Pharmacology: classification of prostanoid receptors: properties, distribution and structure of receptors and their subtypes. Pharmacol Rev. 46:205-229.
23. Chen R, Lewis KA, Perrin MH, Vale WW. 1993 Expression cloning of a human corticotropin-releasing factor receptor. Proc Natl Acad Sci USA. 90:8967-8971.
24. Petraglia F, Sawchenko PE, Rivier J, Vale W. 1987 Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor from cultured placental cells. Nature. 328:717.
25. Moncada S, Palmer RM, Higgs EA. 1991 Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 43:109-142.
26. Myatt L, Brockman DE, Langdon G, Pollock JS. 1993 Constitutive calcium dependent isoform of nitric oxide synthase in the human placental villous vascular tree. Placenta. 14:373-383.
27. Holmes MC, Antoni FA, Szentendrei T. 1984 Pituitary receptors for corticotropin-releasing factor: no effect of vasopressin on binding or activation of adenylate cyclase. Neuroendocrinology. 39:162-169.
28. Petraglia F, Sawchenko PE, Rivier J, Vale W. 1987 Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor from cultured placental cells. Nature. 328:717.
29. Jones SA, Challis JRG. 1990 Effects of corticotropin-releasing hormone and adrenocorticotropin on prostaglandin output by human placenta and fetal membranes. Gynecol Obstet Invest. 29:165-168.
30. 2 and endothelin by nitric oxide in the human fetal-placental circulation. Am J Obstet Gynecol. 166:224-230.
31. Myatt L, Brewer A, Brockman DE. 1991 The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol. 164:687-692.
32. Read MA, Leitch IM, Giles WB, Walters WAW, Boura ALA. 1994 Sodium nitroprusside mediated vasodilatation of the human fetal placental circulation in vitro [Abstract]. Placenta. 15:A59.
33. Gude NM, Xie CY, King RG, et al. 1993 Effects of eicosanoid and endothelial cell derived relaxing factor inhibition on fetal vascular tone and responsiveness in the human perfused placenta. Trophoblast Res. 7:133-145.
34. Read MA, Boura ALA, Walters WAW. 1993 Vascular actions of purines in the fetal circulation of the human placenta. Br J Pharmacol. 110:454-460.
35. Ruth V, Hallman M, Laatikainen T. 1993 Corticotropin-releasing hormone and cortisol in cord plasma in relation to gestational age, labor and fetal distress. Am J Perinatol. 10:115-118.
36. Riley SC, Walton JC, Herlick JM, Challis JRG. 1991 The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. J Clin Endocrinol Metab. 72:1001-1007.
37. Linton EA, Behan DP, Saphier PW, Lowry PJ. 1990 Corticotropin-releasing hormone-binding protein: reduction in adrenocorticotrop-in-releasing activity of placental but not hypothalamic CRH. J Clin Endocrinol Metab. 70:1574-1580.
38. Hinson JP, Vinson GP, Whitehouse BJ, Price GM. 1986 Effect of stimulation on steroid output and perfusion medium flow rate in the isolated perfused rat adrenal gland in situ. J Endocrinol. 109:279-285.
39. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. 1994 Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest. 94:2511-2515.
40. Tsukimori K, Maeda H, Shingu M, Koyanagi T, Nobunaga M, Nakano H. 1992 The possible role of endothelial cells in hypertensive disorders during pregnancy. Obstet Gynecol. 80:229-233.
41. Pinto A, Sorrentino R, Sorrentino P. 1991 Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol. 164:507-513.
42. Brennecke SP, Gude NM, Dilulio JL, King RG. 1994 Nitric oxide synthase activity in human placental villous tissue is reduced in pre-eclampsia [Abstract 1], Proc of the 9th Int Congr for the Study of Hypertension in Pregnancy. 1994;87.